These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16467680)

  • 61. Preparation and Evaluation of Biodegradable Scleral Plug Containing Curcumin in Rabbit Eye.
    Zhang J; Sun H; Zhou N; Zhang B; Ma J
    Curr Eye Res; 2017 Dec; 42(12):1597-1603. PubMed ID: 29111828
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetic and toxicity investigations of a new intraocular lens with a dexamethasone drug delivery system: a pilot study.
    Siqueira RC; Filho ER; Fialho SL; Lucena LR; Filho AM; Haddad A; Jorge R; Scott IU; Cunha Ada S
    Ophthalmologica; 2006; 220(5):338-42. PubMed ID: 16954713
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intravitreal crystalline drug delivery for intraocular proliferation diseases.
    Cheng L; Hostetler K; Valiaeva N; Tammewar A; Freeman WR; Beadle J; Bartsch DU; Aldern K; Falkenstein I
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):474-81. PubMed ID: 19696179
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effects of hypericin on traumatic proliferative vitreoretinopathy in rabbits].
    Gao Q; Hui Y; Wang Y
    Yan Ke Xue Bao; 2002 Dec; 18(4):240-5. PubMed ID: 15515769
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experimental proliferative vitreoretinopathy in rabbits by delivery of bioactive proteins with gelatin microspheres.
    Hirose F; Kiryu J; Tabata Y; Tamura H; Musashi K; Takase N; Usui H; Kuwayama S; Kato A; Yoshimura N; Ogura Y; Yasukawa T
    Eur J Pharm Biopharm; 2018 Aug; 129():267-272. PubMed ID: 29906511
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The significance of fibroblasts in experimental modeling of proliferative vitreoretinopathy].
    Khoroshilova-Maslova IP; Leparskaya NL; Vorotelyak EA; Vasiliev AV
    Vestn Oftalmol; 2017; 133(5):4-10. PubMed ID: 29165406
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy.
    Schiff WM; Hwang JC; Ober MD; Olson JL; Dhrami-Gavazi E; Barile GR; Chang S; Mandava N
    Arch Ophthalmol; 2007 Sep; 125(9):1161-7. PubMed ID: 17846353
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sustained release intravitreal dexamethasone.
    Hainsworth DP; Pearson PA; Conklin JD; Ashton P
    J Ocul Pharmacol Ther; 1996; 12(1):57-63. PubMed ID: 8925398
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathy.
    Oshima Y; Sakamoto T; Hisatomi T; Tsutsumi C; Ueno H; Ishibashi T
    Gene Ther; 2002 Sep; 9(18):1214-20. PubMed ID: 12215888
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of tacrolimus on growth factors in experimental proliferative vitreoretinopathy.
    Turgut B; Uyar F; Ustundag B; Celiker U; Akpolat N; Demir T
    Retina; 2012 Feb; 32(2):232-41. PubMed ID: 21934553
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An intravitreal device providing sustained release of cyclosporine and dexamethasone.
    Enyedi LB; Pearson PA; Ashton P; Jaffe GJ
    Curr Eye Res; 1996 May; 15(5):549-57. PubMed ID: 8670756
    [TBL] [Abstract][Full Text] [Related]  

  • 72. EFFICACY OF INTRAVITREAL INJECTION OF BEVACIZUMAB IN VITRECTOMY FOR PATIENTS WITH PROLIFERATIVE VITREORETINOPATHY RETINAL DETACHMENT: A Meta-analysis of Prospective Studies.
    Zhao XY; Xia S; Wang EQ; Chen YX
    Retina; 2018 Mar; 38(3):462-470. PubMed ID: 28272285
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Microspheres of biodegradable polymers as a drug-delivery system in the vitreous.
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1785-90. PubMed ID: 2032801
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Triamcinolone acetonide in the prevention of experimental proliferative vitreoretinopathy].
    Liang HC; Hui YN; Cai YS
    Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):122-4. PubMed ID: 8001444
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy.
    Turkoz Y; Er H; Borazan M; Yilmaz H; Mizrak B; Parlakpinar H; Cigremis Y
    Mediators Inflamm; 2004 Apr; 13(2):127-30. PubMed ID: 15203555
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery.
    Sundaram V; Barsam A; Virgili G
    Cochrane Database Syst Rev; 2010 Jul; (7):CD006421. PubMed ID: 20614445
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy.
    Shinohara K; Tanaka M; Sakuma T; Kobayashi Y
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):299-305. PubMed ID: 12875458
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics.
    Hou H; Huffman K; Rios S; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2755-63. PubMed ID: 25829415
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
    Kon CH; Occleston NL; Aylward GW; Khaw PT
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.